SEKISUI Diagnostics announced the launch of the OSOM COVID-19 Antigen Home Test to diagnose COVID-19 at home.
The OSOM COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 virus. As with other OSOM Rapid Tests, it is supported by a technical support team of medical technologists/professionals, the company says.
“We are excited to be able to provide consumers with more tools to help diagnose COVID-19 in a fast, easy-to-use format that can be purchased over the counter. This supports our goal of bringing diagnostics to where they are needed most, which in this case is at home, so people do not have to travel to medical facilities and can treat or quarantine quickly”, says Erica Blight, VP of client services, clinical research & Marketing.
Further reading: Sekisui Launches OSOM Ultra Plus Flu A&B Test
SEKISUI Diagnostics is a provider of many rapid testing solutions to the professional market through a portfolio of point-of-care tests under the OSOM and Acucy brands. These tests have provided flexibility to healthcare professionals for decades and are now being brought to the home testing market, according to the company.
“Our entrance into the home testing market is another way we are providing solutions to enhance life with science to improve the health of all people. We understand home testing is a valuable tool and becoming more accepted and necessary, especially when we are experiencing significant waves of respiratory infections as we have seen in previous seasons,” says Bob Schruender, president & CEO of SEKISUI Diagnostics.
Featured image: OSOM COVID-19 Home Test. Photo: SEKISUI Diagnostics
